CVE-2017-0193

Description

Windows Hyper-V in Microsoft Windows Server 2008 SP2 and R2 SP1, Windows 7 SP1, Windows 8.1, Windows Server 2012 Gold and R2, Windows RT 8.1, Windows 10 Gold, 1511, 1607, 1703, and Windows Server 2016 allows an attacker to gain elevated privileges on a target guest operating system when Windows Hyper-V instruction emulation fails to properly enforce privilege levels, aka "Hypervisor Code Integrity Elevation of Privilege Vulnerability".

Category

7.8
CVSS
Severity: High
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.39%
Vendor Advisory microsoft.com
Affected: Microsoft Corporation Microsoft Windows
Published at:
Updated at:

References

Link Tags
http://www.securitytracker.com/id/1038670 vdb entry
http://www.securityfocus.com/bid/98878 vdb entry third party advisory
https://portal.msrc.microsoft.com/en-US/security-guidance/advisory/CVE-2017-0193 patch vendor advisory mitigation

Frequently Asked Questions

What is the severity of CVE-2017-0193?
CVE-2017-0193 has been scored as a high severity vulnerability.
How to fix CVE-2017-0193?
To fix CVE-2017-0193, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2017-0193 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2017-0193 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2017-0193?
CVE-2017-0193 affects Microsoft Corporation Microsoft Windows.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.